Mike R Russell
Overview
Explore the profile of Mike R Russell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
807
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capasso M, McDaniel L, Cimmino F, Cirino A, Formicola D, Russell M, et al.
J Cell Mol Med
. 2017 Jul;
21(12):3224-3230.
PMID: 28667701
The genetic aetiology of sporadic neuroblastoma is still largely unknown. We have identified diverse neuroblastoma susceptibility loci by genomewide association studies (GWASs); however, additional SNPs that likely contribute to neuroblastoma...
2.
Hart L, Rader J, Raman P, Batra V, Russell M, Tsang M, et al.
Clin Cancer Res
. 2016 Oct;
23(7):1785-1796.
PMID: 27729458
Neuroblastoma is treated with aggressive multimodal therapy, yet more than 50% of patients experience relapse. We recently showed that relapsed neuroblastomas frequently harbor mutations leading to hyperactivated ERK signaling and...
3.
Russell M, Penikis A, Oldridge D, Alvarez-Dominguez J, McDaniel L, Diamond M, et al.
Cancer Res
. 2015 Jun;
75(15):3155-66.
PMID: 26100672
Chromosome 6p22 was identified recently as a neuroblastoma susceptibility locus, but its mechanistic contributions to tumorigenesis are as yet undefined. Here we report that the most highly significant single-nucleotide polymorphism...
4.
Diskin S, Capasso M, Diamond M, Oldridge D, Conkrite K, Bosse K, et al.
J Natl Cancer Inst
. 2014 Mar;
106(4):dju047.
PMID: 24634504
TP53 is the most frequently mutated gene in human malignancies; however, de novo somatic mutations in childhood embryonal cancers such as neuroblastoma are rare. We report on the analysis of...
5.
Rader J, Russell M, Hart L, Nakazawa M, Belcastro L, Martinez D, et al.
Clin Cancer Res
. 2013 Sep;
19(22):6173-82.
PMID: 24045179
Purpose: Neuroblastoma is a pediatric cancer that continues to exact significant morbidity and mortality. Recently, a number of cell-cycle proteins, particularly those within the Cyclin D/CDK4/CDK6/RB network, have been shown...
6.
Liu Q, Russell M, Shahriari K, Jernigan D, Lioni M, Garcia F, et al.
Cancer Res
. 2013 Mar;
73(11):3297-305.
PMID: 23536554
Despite the progress made in the early detection and treatment of prostate adenocarcinoma, the metastatic lesions from this tumor are incurable. We used genome-wide expression analysis of human prostate cancer...
7.
Russell M, Levin K, Rader J, Belcastro L, Li Y, Martinez D, et al.
Cancer Res
. 2012 Nov;
73(2):776-84.
PMID: 23135916
Neuroblastoma is uniquely sensitive to single-agent inhibition of the DNA damage checkpoint kinase Chk1, leading us to examine downstream effectors of this pathway and identify mitotic regulator Wee1 as an...
8.
Cole K, Huggins J, LaQuaglia M, Hulderman C, Russell M, Bosse K, et al.
Proc Natl Acad Sci U S A
. 2011 Feb;
108(8):3336-41.
PMID: 21289283
Neuroblastoma is a childhood cancer that is often fatal despite intense multimodality therapy. In an effort to identify therapeutic targets for this disease, we performed a comprehensive loss-of-function screen of...
9.
Russell M, Liu Q, Fatatis A
Clin Cancer Res
. 2010 Sep;
16(20):5002-10.
PMID: 20813817
Purpose: Platelet-derived growth factor α (PDGFRα) is highly expressed in primary prostate cancer and associated skeletal metastases. Here, we tested whether targeting this receptor could impair metastatic colonization and progression,...
10.
Russell M, Liu Q, Lei H, Kazlauskas A, Fatatis A
Cancer Res
. 2010 May;
70(10):4195-203.
PMID: 20442296
Prostate adenocarcinoma is the second leading cause of cancer death among men, due primarily to the fact that the majority of prostate cancers will eventually spread to the skeleton. Metastatic...